Search Results for "Pharma New Product Launch India"

19:07 EDT 2nd July 2015 | BioPortfolio

Matching Channels


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...


Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Matching News

India SRF buys DuPont's Dymel business and plans pharma plant

India SRF will set up a pharma-grade inhaler propellant manufacturing plant in India with tech and knowhow acquired from US chemical company DuPont.

Indian government sets up pharma 'made in India' committee

To boost development of pharma sector that sources APIs in India

Cantor ups Flex Pharma price target to $27

Cantor Fitzgerald has raised its price target for Flex Pharma (NASDAQ:FLKS) to $27 from $22 to reflect the pre-launch for the company’s consumer product for exercise associated muscle cramps (EAMC)....

Nutra Pharma Provides Updates on Marketing and Distribution of Nyloxin(R) to India / Nutra Pharma Is Providing an Update on the Company's Efforts to Market and Distribute Their Over-the-Counter (OTC) Pain Reliever, Nyloxin(R) in India

CORAL SPRINGS, FL -- (Marketwired) -- 04/15/15 -- Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis ...

TVM Capital: Investments from Scotland to India

In the last in the series of interviews from the BIA Leadership Summit, Dr Fintan Walton talks to Simon Best, Entrepreneur-in-House at TVM Capital. Simon’s background was in agriculture. He is based...

India Plans Pharma Clusters to Cut China API Dependence

India is fast-tracking an exhaustive action plan that aims to cut the local pharma industry’s growing dependence on China for raw materials to eventually reach self-reliance.

BIG PICTURE - Epistem's Genedrive India launch is inflection point

Epistem’s green light to launch its flagship Genedrive diagnostic test for killer disease TB in India marks an inflection point for the firm.

Doctors in India plan to launch network against corruption and unethical practices

A group of doctors in India have announced plans to launch a campaign to curb what some of its members describe as rampant commercialisation trends and widespread unethical and irrational practices......

Matching PubMed Articles

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

Medical barriers to emergency contraception: a cross-sectional survey of doctors in North India.

Some medical doctors in India have publicly expressed opposition to making emergency contraceptive pills (ECPs) easily accessible, even though ECPs are included in the method mix of the Ministry of He...

Promoting patient safety in India: Situational analysis and the way forward.

Unsafe healthcare is a well-recognized issue internationally and is attracting attention in India as well. Drawing upon the various efforts that have been made to address this issue in India and abroa...

Genetic Diversity of Enterovirus A71, India.

We have identified circulation of 3 genogroups of enterovirus (EV) A71 in India. A new genogroup (proposed designation G) was discovered during this study. We isolated genogroups D and G in wide geogr...

Search Whole site using Google


Advertisement Advertisement